Posts Tagged ‘facultyresearch’
UC Berkeley Awards $200K Venture Grant to HypO2Regen Therapeutics
Professor Phil Messersmith and colleagues have launched HypO2Regen Therapeutics, a startup developing novel, disease-modifying therapeutics for chronic intractable inflammatory diseases, including the first cell-free stem cell treatment that induces true regeneration of damaged tissue. Their first effort takes aim at periodontitis, which affects over 300 million people worldwide.
Read MoreLareau named MTI Innovator
Professor Liana Lareau is recognized for her revolutionary approach to treat retinitis pigmentosa and other dominant genetic diseases by combining CRISPR prime editing with machine learning.
Read MoreThe not-so-secret life of gut bacteria
Computational modeling from Mofrad Lab gives us a peek inside these important microbial communities.
Read MoreMessersmith’s AsparaGlue named East Bay Innovation Awardee
Berkeley startup AsparaGlue, founded on science by Professor Phil Messersmith and postdoc Subhajit Pal, won an East Bay Innovation Award for their bioinspired surgical superglue.
Read MoreAI can now model and design the genetic code for all domains of life with Evo 2
Research led by Professor Patrick Hsu has produced Evo 2, the largest AI model in biology to date, which can accurately predict the effects of all types of genetic mutations.
Read MoreArkin Lab receives ARPA-H award for microbiome engineering
Adam Arkin has been granted an award of over $20 million from the Advanced Research Projects Agency for Health (ARPA-H) to pursue microbiome engineering to create probiotic bacterial communities that prevent and treat lung pathogens.
Read MoreDelcassian receives seed funding for cancer research
Professor Derfogail Delcassian has been awarded $1 million in non-dilutive seed funding to accelerate the commercialization of her work on targeted molecular therapies for hard-to-treat cancers.
Read MoreAcid-degradable lipid nanoparticles enhance the delivery of mRNA
Research by Niren Murthy’s lab presents a new acid-degradable linker that rapidly hydrolyzes in endosomes but is stable in the blood, which could significantly increase the efficiency of delivering mRNA-based therapies to cells.
Read MoreNew recyclable adhesives can be easily adapted for medical, consumer and industrial applications
Messersmith Lab has created a family of polymers from a stabilized alpha-lipoic acid which could lead to versatile, high-performance and environmentally friendly recyclable adhesives.
Read More